Jartti, Tuomas
Bønnelykke, Klaus
Elenius, Varpu
Feleszko, Wojciech http://orcid.org/0000-0001-6613-2012
Funding for this research was provided by:
Paulon Säätiö
Tampereen Tuberkuloosisäätiö
Finnish Allergology and Immunology Foundation
Fundacja Respira
Article History
Received: 2 October 2019
Accepted: 8 January 2020
First Online: 27 January 2020
Compliance with ethical standards
:
: WF has received speaker honoraria from Vifor Pharma. VE and KB declare that they have no conflict of interest.